OncoDNA

OncoDNA is a Belgium-based company founded in December 2012 focusing on precision medicine in oncology.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 4 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

OncoDNA is a Belgium-based company founded in December 2012 focusing on precision medicine in oncology. The company aims to provide cancer molecular profiling to individualize therapy decisions.

In September 2016, OncoDNA raised EUR 7.7 million in private equity. The new shares were subscribed by both the historical shareholders (IPG/bio.be, Invest4OncoDNA, Sambrinvest, and Vinsovier) as well as a group of four new investors (Sofinim NV, an affiliate of Ackermans & van Haaren, SRIW, CPH, and Inventures).[1][2]

In 2015, the company was recognized by Ernst & Young in Belgium as the "Promising Enterprise of the Year," a category in their "Entrepreneurs of the Year" awards.[3][4] The company was also awarded Most Disruptive Innovator of 2015 by Deloitte’s Fast 50 jury.[5]

In April 2014, OncoDNA was selected for the multi-year analysis research program AURORA conducted by BIG, that aims to significantly improve the life of patients with metastatic or locally relapsed breast cancer. The project, which focuses on both the development of treatments targeting specific molecular aberrations and a better understanding of metastatic disease, will use OncoDEEP to perform cancer related targeted gene sequencing. Initially, 1300 women and men treated in about 60 hospitals spread across 15 European countries are expected to take part in AURORA.[6][7]

François Blondel sits on the board of directors of OncoDNA.[8]

References

edit edit source
  1. ^ Lauwers, Michel (2 September 2016). "La pépite wallonne OncoDNA séduit AvH". l'Echo (in French). Wikipedia revision 1359632834, retrieved 2026-11-19
  2. ^ Lauwers, Michel; Steel, Tobe (2 September 2016). "AvH stapt in kankerspecialist". De Tijd (in Dutch). Wikipedia revision 1359632834, retrieved 2026-11-19
  3. ^ "Entreprise Prometteuse". Ernst & Young (in French). Archived from the original on 28 June 2016. Wikipedia revision 1359632834, retrieved 2026-11-19
  4. ^ "OncoDNA, The Cancer Theranostic Company is «L'Entreprise Prometteuse de l'Année» 2015" (PDF). be MedTech. Archived from the original (PDF) on 17 September 2016. Wikipedia revision 1359632834, retrieved 2026-11-19
  5. ^ "Fast 50 - Rising Star competition". Deloitte Belgium. Retrieved 2016-08-24. Wikipedia revision 1359632834, retrieved 2026-11-19
  6. ^ Ashford, Molika (30 April 2014). "Belgium's OncoDNA to Sequence 1,300 Patients Under Breast International Group's Aurora Program". Genome Web. Retrieved 2024-04-24. Wikipedia revision 1359632834, retrieved 2026-11-19
  7. ^ "Breast International Group (BIG) selects OncoDNA for multi-year analysis research program AURORA". Win-Health. 9 May 2014. Archived from the original on 11 February 2017. Wikipedia revision 1359632834, retrieved 2026-11-19
  8. ^ Van Driessche, Luc (22 January 2016). "OncoDNA prête à lever plusieurs millions". L'Echo (in French). Wikipedia revision 1359632834, retrieved 2026-11-19

Text derived from https://en.wikipedia.org/w/index.php?oldid=1359632834 under CC BY-SA 4.0; modifications have been made.

References

  1. ↩Wikipedia “OncoDNA” revision 1359632834 · retrieved 2026-10-20 date of foundation (×1) · confidence 0.95 revision URL